As on Wednesday, Aptevo Therapeutics Inc (NASDAQ: APVO) got off with the flyer as it spiked 6.67% to $1.28, before settling in for the price of $1.2 at the close. Taking a more long-term approach, APVO posted a 52-week range of $1.04-$298.00.
The Healthcare sector firm’s twelve-monthly sales growth has been 80.96% for the last half of the decade. Meanwhile, its Annual Earning per share during the time was 80.96%. Nevertheless, stock’s Earnings Per Share (EPS) this year is 99.69%. This publicly-traded company’s shares outstanding now amounts to $16.85 million, simultaneously with a float of $16.83 million. The organization now has a market capitalization sitting at $21.57 million. At the time of writing, stock’s 50-day Moving Average stood at $1.4942, while the 200-day Moving Average is $13.1586.
Aptevo Therapeutics Inc (APVO) Ownership Facts and Figures
Another important factor to analyze is how key investors are playing towards the stock of the Biotechnology industry. Aptevo Therapeutics Inc’s current insider ownership accounts for 0.10%, in contrast to 7.19% institutional ownership. According to the most recent insider trade that took place on Nov 10 ’25, this organization’s Director bought 13,513 shares at the rate of 1.49, making the entire transaction reach 20,134 in total value, affecting insider ownership by 13,514.
Aptevo Therapeutics Inc (APVO) Earnings and Revenue Records
Aptevo Therapeutics Inc’s EPS increase for this current 12-month fiscal period is 99.69% and is forecasted to reach -1.60 in the upcoming year. Considering the longer run, market analysts have predicted that Company’s EPS will increase by 90.39% through the next 5 years, which can be compared against the 80.96% growth it accomplished over the previous five years trading on the market.
Aptevo Therapeutics Inc (NASDAQ: APVO) Trading Performance Indicators
Let’s observe the current performance indicators for Aptevo Therapeutics Inc (APVO). It’s Quick Ratio in the last reported quarter now stands at 4.03.
In the same vein, APVO’s Diluted EPS (Earnings per Share) trailing twelve months is recorded -185.07, a figure that is expected to reach -0.45 in the next quarter, and analysts are predicting that it will be -1.60 at the market close of one year from today.
Technical Analysis of Aptevo Therapeutics Inc (APVO)
Through scrutinizing the latest numbers posted by the [Aptevo Therapeutics Inc, APVO], it can be observed that its last 5-days Average volume of 0.68 million was lower the volume of 2.32 million, it posted the year before. During the previous 9 days, stock’s Stochastic %D was recorded 40.51% While, its Average True Range was 45.76.
Raw Stochastic average of Aptevo Therapeutics Inc (APVO) in the period of the previous 100 days is set at 10.62%, which indicates a major fall in contrast to 46.15% during the last 2-weeks. If we go through the volatility metrics of the stock, In the past 14-days, Company’s historic volatility was 0.0911 that was lower than 0.1471 volatility it exhibited in the past 100-days period.
